Drugmakers plan US price hikes on more than 350 medications
The costs of at least 350 drugs in the U.S. are expected to rise in 2026, according to a new analysis, despite many of the drugmakers pledging to offer more favorable prices under new Trump administration policies.
New data from the health care research firm 3 Axis Advisors, first reported by Reuters, found that a higher number of drugs would see price increases next year compared with last year, when more than 250 drugs were slated for markups.
The median price hike hovers around 4 percent.
Tagged: Healthcare BACK TO HOMEPAGE